迈威生物：二级市场的股价受多重因素影响

Core Viewpoint - Maiwei Biotech acknowledges that its stock price in the secondary market is influenced by multiple factors and emphasizes its commitment to developing its core business to provide better returns for shareholders [2]. Group 1 - The company is actively monitoring the performance of its stock price in the secondary market [2]. - Maiwei Biotech is focused on enhancing its main business operations [2]. - The company aims to deliver improved investment returns to its shareholders [2].